
    study terminated on 7 april 2015 for business reasons. no safety and/or efficacy concerns
    contributed to the termination of the study
  
['pulmonary disease, chronic obstructive']
['placebo', 'pf-03715455']

        Inclusion Criteria:

          -  Female subjects of non-childbearing potential and male subjects between the ages of 40
             and 80 years, inclusive

          -  Subjects with a diagnosis, for at least 6 months, of moderate to severe COPD and who
             meet the criteria for Stage II-III disease

          -  Subjects must have a smoking history of at least 10 pack-years

        Exclusion Criteria:

          -  Current evidence or history within the previous 6 months of any clinically significant
             disease (other than COPD) or abnormality in the opinion of the Investigator that would
             put the subject at risk or which would compromise the quality of the study data

          -  A COPD exacerbation requiring treatment with oral steroids or hospitalization for the
             treatment of COPD within 3 months of Screening
      